Literature DB >> 24778927

Protein tyrosine phosphatases as wardens of STAT signaling.

Frank-D Böhmer1, Karlheinz Friedrich2.   

Abstract

Signaling by signal transducers and activators of transcription (STATs) is controlled at many levels of the signaling cascade. Protein tyrosine phosphatases (PTPs) regulate STAT activation at several layers, including direct pSTAT dephosphorylation in both cytoplasm and nucleus. Despite the importance of this regulation mode, many aspects are still incompletely understood, e.g., the identity of PTPs acting on certain members of the STAT family. After a brief introduction into the STAT and PTP families, we discuss here the current knowledge on PTP mediated regulation of STAT activity, focusing on the interaction of individual STATs with specific PTPs. Finally, we highlight open questions and propose important tasks of future research.

Entities:  

Keywords:  PTP; STAT; dephosphorylation; protein tyrosine phosphatase; signal transducer and activator of transcription

Year:  2014        PMID: 24778927      PMCID: PMC3995736          DOI: 10.4161/jkst.28087

Source DB:  PubMed          Journal:  JAKSTAT        ISSN: 2162-3988


  107 in total

1.  TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B.

Authors:  M P Myers; J N Andersen; A Cheng; M L Tremblay; C M Horvath; J P Parisien; A Salmeen; D Barford; N K Tonks
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

2.  SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ.

Authors:  Andreas Begitt; Mathias Droescher; Klaus-Peter Knobeloch; Uwe Vinkemeier
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

Review 3.  Modulation of leptin resistance by protein tyrosine phosphatases.

Authors:  Julie St-Pierre; Michel L Tremblay
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

4.  High-throughput RNAi screening to dissect cellular pathways: a how-to guide.

Authors:  Christina Falschlehner; Sandra Steinbrink; Gerrit Erdmann; Michael Boutros
Journal:  Biotechnol J       Date:  2010-04       Impact factor: 4.677

Review 5.  PTP1B and TC-PTP: regulators of transformation and tumorigenesis.

Authors:  Matthew Stuible; Karen M Doody; Michel L Tremblay
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

6.  From the nucleus to the mitochondria and back: the odyssey of a multitask STAT3.

Authors:  Marco Demaria; Valeria Poli
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 7.  Suppression of cytokine signaling: the SOCS perspective.

Authors:  Edmond M Linossi; Jeffrey J Babon; Douglas J Hilton; Sandra E Nicholson
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

Review 8.  Regulation of protein tyrosine phosphatases by reversible oxidation.

Authors:  Arne Ostman; Jeroen Frijhoff; Asa Sandin; Frank-D Böhmer
Journal:  J Biochem       Date:  2011-08-19       Impact factor: 3.387

9.  Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.

Authors:  Minghao Zhong; Melissa A Henriksen; Kenji Takeuchi; Olaf Schaefer; Bin Liu; Johanna ten Hoeve; Zhiyong Ren; Xiang Mao; Xiaomin Chen; Ke Shuai; James E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

10.  Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases.

Authors:  Tianshuang Liu; Shawn Castro; Allan R Brasier; Mohammad Jamaluddin; Roberto P Garofalo; Antonella Casola
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

View more
  36 in total

Review 1.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

2.  T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells.

Authors:  Moorthy Krishnan; Declan F McCole
Journal:  Ann N Y Acad Sci       Date:  2017-08-14       Impact factor: 5.691

3.  Cucurbitacin I inhibits STAT3, but enhances STAT1 signaling in human cancer cells in vitro through disrupting actin filaments.

Authors:  Hui Guo; Shan Kuang; Qiao-Ling Song; Man Liu; Xiao-Xiao Sun; Qiang Yu
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

4.  Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.

Authors:  Katja G Weinacht; Louis-Marie Charbonnier; Fayhan Alroqi; Ashley Plant; Qi Qiao; Hao Wu; Clement Ma; Troy R Torgerson; Sergio D Rosenzweig; Thomas A Fleisher; Luigi D Notarangelo; Imelda C Hanson; Lisa R Forbes; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2017-01-27       Impact factor: 10.793

5.  Organic dust induces inflammatory gene expression in lung epithelial cells via ROS-dependent STAT-3 activation.

Authors:  Kartiga Natarajan; Velmurugan Meganathan; Courtney Mitchell; Vijay Boggaram
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-05-01       Impact factor: 5.464

6.  DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate.

Authors:  Thomas Hill; Robert H Rice
Journal:  Toxicol In Vitro       Date:  2017-10-12       Impact factor: 3.500

Review 7.  Mechanisms and consequences of Jak-STAT signaling in the immune system.

Authors:  Alejandro V Villarino; Yuka Kanno; John J O'Shea
Journal:  Nat Immunol       Date:  2017-03-22       Impact factor: 25.606

8.  E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity.

Authors:  Donald W Lawrence; Jacki Kornbluth
Journal:  Cell Signal       Date:  2016-08-26       Impact factor: 4.315

9.  Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Authors:  Hui-Ming Chen; William van der Touw; Yuan Shuo Wang; Kyeongah Kang; Sunny Mai; Jilu Zhang; Dayanira Alsina-Beauchamp; James A Duty; Sathish Kumar Mungamuri; Bin Zhang; Thomas Moran; Richard Flavell; Stuart Aaronson; Hong-Ming Hu; Hisashi Arase; Suresh Ramanathan; Raja Flores; Ping-Ying Pan; Shu-Hsia Chen
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

Review 10.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.